| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.03 |